The group is recognized for the development of novel field-effect transistor biosensors. Their work sets a new standard in rigorous, quantitative measurements of pH and biomolecular response, enabling fundamental examinations of function, rapid evaluation of therapeutic efficacy, medical diagnostics, and environmental control in pharmaceutical manufacturing. Their sensors are 100 times more sensitive with 10 times better resolution than conventional devices, providing a powerful new tool for drug design and advanced manufacturing.